BIONIC: Turning Neuroscientific Insight Into a Commercial Neuromodulation Device, Twice

In this inspiring keynote, Professor Tim Denison—physicist, engineer, and former Medtronic VP of Research—shares his vision for the future of neurotechnology and the global innovation ecosystem driving it. Now based at Oxford as a UK government–funded Chair in Emerging Technology, Denison reflects on the “rhythms” that shape both biology and technological progress, highlighting how engineering, neuroscience, and clinical care must evolve together to create meaningful patient impact. He contrasts the stagnation of pharmaceutical innovation with the exponential growth of semiconductor and electronics capabilities, arguing that neurotechnology can complement traditional medicine by applying “Moore’s Law thinking” to developing smarter, responsive neuromodulation therapies. Denison emphasizes the importance of closed‑loop and predictive systems, inspired by natural rhythms like circadian cycles, to build devices that adapt in real time and potentially reshape long‑term disease trajectories. The keynote also outlines lessons learned from large‑scale translational efforts—including the NIH BRAIN Initiative, next‑generation DBS systems, and global public‑private collaboration. Denison describes how aligned engineering, business models, regulation, and clinical workflows are essential “missing ingredients” in scaling neurotechnology from lab prototypes to real‑world impact. He closes by introducing the UK’s new £50 million neurotechnology infrastructure investment, aimed at accelerating device development, expanding access, and enabling future breakthroughs in conditions from epilepsy to incontinence to neurodegeneration. 00:00 Introduction to Tim Denison 00:31 Career Background & Oxford Appointment 01:27 Rhythms of Life, Rhythms of Innovation 02:35 UK Emerging Technology Chair & Industry‑Building Mission 03:08 Collaborators, Clinical Partners & Global Work 03:44 Early Sci‑Fi Neurotech Concepts (1958 Brain Amplifier) 05:14 Why Neurotechnology Matters: Disease Burden & Under‑Treatment 05:56 Pharma’s E‑Room’s Law vs. Engineering’s Moore’s Law 06:45 Vision: Bioelectronic Medicine & Restoring Physiology 07:56 Lessons from Nature: Bees, Predictive Biology & Circadian Rhythms 09:44 Opportunities for Chronotype‑Driven Neuromodulation 10:25 The “Missing Ingredients” in Translation: Economics, Workflow & Regulation 11:29 Innovation Reality Check: Building What’s Viable 12:24 Technology Lifecycles & the S‑Curve of Neuromodulation 13:58 From Human‑in‑the‑Loop to Closed‑Loop Therapies 16:10 Translational Platforms: PC+S, BRAIN Initiative & Clinical Ecosystem 19:42 Ecosystem 2.0: UK Public–Private Neurotechnology Infrastructure 23:40 Future Vision: Scalable Global Therapies & Long‑Term Impact From Mayo Clinic to your inbox (free): https://www.mayoclinic.org/patient-visitor-guide/newsletters Visit Mayo Clinic: https://www.mayoclinic.org Connect with Mayo Clinic: Facebook: https://www.facebook.com/mayoclinic Instagram: https://www.instagram.com/mayoclinic X: https://x.com/MayoClinic Threads: https://www.threads.net/@mayoclinic